News summary

City of Lynn, Massachusetts Earns 2026 New England Employee Benefits Council Best Practice Award for Innovative Approach to GLP-1 Coverage and Obesity Management

Source: PR Newswire • Published: 22 Oct 2026, 08:35

Summarized by Masters of Longevity from PR Newswire.

A municipal employer case study detailing an award-winning, employer-led obesity care model that pairs structured medication access with behavioral and clinical support.

City of Lynn, Massachusetts Earns 2026 New England Employee Benefits Council Best Practice Award for Innovative Approach to GLP-1 Coverage and Obesity Management
Key Takeaways
  • The City of Lynn implemented a 24-month obesity program combining personalized coaching, clinical oversight, and up to 12 GLP-1 medication fills per participant.
  • Participants averaged 20% weight loss with 85% maintaining results after medication therapy ended.
  • The program reduced prescription costs by about $14,000 per participant and showed GLP-1 utilization 50% lower than peer organizations.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.